Director sold ~$125K of Teradyne
Scheduled in advanceTraded Nov 12, 2025 · Filed Nov 14, 2025
The boss of Teradyne sold $200K of Teradyne shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$199,662
Shares × reported transaction price
14 days after results of Oct 29, 2025, 83 days before results of Feb 3, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $179.27 on Nov 12, 2025, within 5% of its 52-week high, after a 27% rise over the previous 30 trading days
52-week range $67.96 (Apr 8, 2025) to $187.59 (Nov 5, 2025), 93% of the way up, from 250 adjusted closes. 30 trading days earlier: $141.12 on Oct 1, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -0.9% | +0.5% | -1.3% |
| 30 days | +10.6% | +0.9% | +9.8% |
| 90 days | +82.5% | +2.6% | +79.9% |
| 180 days | +91.7% | +11.0% | +80.8% |
Past results only. Not a forecast.
Director sold ~$125K of Teradyne
Scheduled in advanceHeld by the filer's spouse per the disclosure. Disclosed 22 days after the transaction; reported as an official range, not an exact amount.
Held by the filer's spouse per the disclosure. Disclosed 22 days after the transaction; reported as an official range, not an exact amount.